Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 61 - 80 of 100
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
The U.S. Food and Drug Administration's Oncology Center of Excellence, Project Community, has designated June 17 to June 23 as National Black Family Cancer Awareness Week. The week coincides with Juneteenth—an important date in our nation’s history that marks and celebrates the end of slavery in the United States. By participating in the #BlackFamCan social media effort, ACCC is building support and …
As City of Hope embarkes on the development of an experimental COVID-19 vaccine currently in a phase I clinical trial, ACCCBuzz spoke with Dr. Sanjeet Dadwal about the investigational vaccine’s safety and efficacy, potential emergency use authorization (EUA), and suitability for patients with cancer.
One of the ways in which community oncology is helping to close gaps in cancer research is through participation in the National Cancer Institute Community Oncology Research Program clinical trials. The Lahey Health Cancer Institute, a part of the Beth Israel Lahey Health System, continues to expand access to clinical trials and, in particular, the NCI National Clinical Trials Network into the community …
Rather than fielding its annual Trending Now in Cancer Care survey while cancer programs were experiencing unprecedented challenges due to the extended public health emergency, ACCC chose to facilitate conversations with its members to capture the lived experiences of the most pertinent issues impacting oncology practice and care delivery.
One important step toward supporting the health of Indigenous Peoples was the opening of the Center for Indigenous Cancer Research (CICR) at Roswell Park Comprehensive Cancer Center in January 2020. Its mission: to reduce the impact of cancer on Indigenous communities regionally, nationally, and internationally.
Oncology Issues sat down with Dr. Schilsky to look back on his career and look forward to future research breakthroughs in this era of COVID-19 and beyond.
Older adults with cancer are consistently precluded from participating in clinical trials for promising new treatments. A multi-pronged approach is required to ensure trials are developed for all patients, including paying specific attention to inclusion/exclusion criteria and creating clinically meaningful endpoints that can enhance enrollment efforts in underserved populations.
The disparities in prostate cancer are striking. In the United States, Black men continue to experience a far greater incidence of new prostate cancers and are 2.2 to 2.5 times more likely to die from the disease than any other racial/ethnic group. Taking action to close these gaps is an imperative for moving toward equitable cancer care.
April 20, 2021
An expert panel reviews currently available data on cancer care disparities, discusses the needs of disadvantaged populations, and shares practical solutions and methods for implementing bias training. (April 20, 2021)
Poor access to care among AYA patients is not only evident in low clinical trial enrollment. The struggle to access much-needed care continues when treatment concludes. Most AYA cancer survivors must learn to navigate follow-up medical care on their own.
The Road to Recovery Report makes specific recommendations for maintaining the adaptations made necessary to accommodate the disruptions caused by the pandemic. Where possible, the report recommends building on that momentum to spur much-needed change in cancer care and research.
Assuming the ACCC presidency in March of 2020, just as the COVID-19 public health emergency went into effect, was certainly a dramatic way to enter office. That said, I am pleased with how much we have accomplished these last 12 months— despite the nationwide shutdown and ongoing pandemic.
Montana is one of the most rural states in the U.S., with nearly half of its population living in rural regions. Accordingly, accessing healthcare services can be difficult for Montana’s citizens, and gaining access to clinical trials is particularly challenging.
COVID-19 has highlighted how challenging it is for cancer care providers large and small when healthcare resources are limited. One oncologist shares her experience on a task force that drafted a series of recommendations for moving forward in cancer care as the pandemic recedes.
February 10, 2021
An expert panel of past ACCC Presidents will share their perspectives on changes to clinical research during the pandemic.
ACCCBuzz sat down with ASCO's Dr. Richard L. Schilsky to look back on his career and look forward to the future breakthroughs in this era and beyond.
January 27, 2021
Optimal care delivery changes from place to place—what works best for one location and patient population may not be ideal for another. The same applies to cancer research. Understanding the needs of your patient population is critical to trial design and implementation. How can you proactively involve your community in cancer research activities? (January 27, 2021)
Carla Strom, MLA, speaks with ACCCBuzz about her role as an advocate, how this role has evolved, and why listening to the community's voice early and often in clinical trial development and cancer research is vital.
Learn how the PECaD program at Siteman Cancer Center is decreasing disparities in care by monitoring data, engaging the community, supporting research, and ensuring diverse representation in research.
    Displaying results 61 - 80 of 100
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »